Advertisement
Screener

PRA Health Sciences, Inc. Share-based Payment Arrangement, Expense

PRA Health Sciences, Inc. Share-based Payment Arrangement, Expense

PRA Health Sciences, Inc. reported Share-based Payment Arrangement, Expense of $18.77 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-04-29.

Discontinued › Expense Statement › Operating Expenses

us-gaap:AllocatedShareBasedCompensationExpense · last filed 2021-04-29

  • PRA Health Sciences, Inc. share-based payment arrangement, expense for the quarter ending 2021-03-31 was $18.77M, a 21.70% increase year-over-year.
  • PRA Health Sciences, Inc. share-based payment arrangement, expense for the quarter ending 2020-12-31 was $18.80M, a 21.86% increase year-over-year.
  • PRA Health Sciences, Inc. share-based payment arrangement, expense for the quarter ending 2020-09-30 was $19.34M, a 72.03% increase year-over-year.
  • PRA Health Sciences, Inc. share-based payment arrangement, expense for the quarter ending 2020-06-30 was $15.85M, a 59.79% increase year-over-year.
  • PRA Health Sciences, Inc. share-based payment arrangement, expense for fiscal 2020 was $69.41M, a 51.44% increase from fiscal 2019.
  • PRA Health Sciences, Inc. share-based payment arrangement, expense for fiscal 2019 was $45.83M, a 53.21% increase from fiscal 2018.
  • PRA Health Sciences, Inc. share-based payment arrangement, expense for fiscal 2018 was $29.92M.
Period endShare-based Payment Arrangement, Expense 3 monthShare-based Payment Arrangement, Expense 6 monthShare-based Payment Arrangement, Expense 9 monthShare-based Payment Arrangement, Expense 12 month
2021-03-31$18.77M
10-Q · filed 2021-04-29
$37.57M
derived: sum of 2 quarters · filed 2021-04-29
$56.91M
derived: sum of 3 quarters · filed 2021-04-29
$72.76M
derived: sum of 4 quarters · filed 2021-04-29
2020-12-31$18.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
$38.14M
derived: sum of 2 quarters · filed 2021-02-24
$53.99M
derived: sum of 3 quarters · filed 2021-02-24
$69.41M
10-K · filed 2021-02-24
2020-09-30$19.34M
10-Q · filed 2020-11-05
$35.19M
derived: sum of 2 quarters · filed 2020-11-05
$50.61M
10-Q · filed 2020-11-05
$66.04M
derived: sum of 4 quarters · filed 2021-04-29
2020-06-30$15.85M
10-Q · filed 2020-08-07
$31.27M
10-Q · filed 2020-08-07
$46.70M
derived: sum of 3 quarters · filed 2021-04-29
$57.94M
derived: sum of 4 quarters · filed 2021-04-29
2020-03-31$15.43M
10-Q · filed 2021-04-29
$30.85M
derived: sum of 2 quarters · filed 2021-04-29
$42.10M
derived: sum of 3 quarters · filed 2021-04-29
$52.01M
derived: sum of 4 quarters · filed 2021-04-29
2019-12-31$15.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
$26.67M
derived: sum of 2 quarters · filed 2021-02-24
$36.59M
derived: sum of 3 quarters · filed 2021-02-24
$45.83M
10-K · filed 2021-02-24
2019-09-30$11.24M
10-Q · filed 2020-11-05
$21.16M
derived: sum of 2 quarters · filed 2020-11-05
$30.41M
10-Q · filed 2020-11-05
$39.08M
derived: sum of 4 quarters · filed 2021-02-24
2019-06-30$9.92M
10-Q · filed 2020-08-07
$19.16M
10-Q · filed 2020-08-07
$27.84M
derived: sum of 3 quarters · filed 2021-02-24
$36.38M
derived: sum of 4 quarters · filed 2021-02-24
2019-03-31$9.25M
10-Q · filed 2020-05-01
$17.92M
derived: sum of 2 quarters · filed 2021-02-24
$26.46M
derived: sum of 3 quarters · filed 2021-02-24
$32.86M
derived: sum of 4 quarters · filed 2021-02-24
2018-12-31$8.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
$17.22M
derived: sum of 2 quarters · filed 2021-02-24
$23.62M
derived: sum of 3 quarters · filed 2021-02-24
$29.92M
10-K · filed 2021-02-24
2018-09-30$8.54M
10-Q · filed 2019-10-31
$14.94M
derived: sum of 2 quarters · filed 2019-10-31
$21.24M
10-Q · filed 2019-10-31
2018-06-30$6.40M
10-Q · filed 2019-08-01
$12.70M
10-Q · filed 2019-08-01
2018-03-31$6.30M
10-Q · filed 2019-05-02
2017-09-30$8.74M
10-Q · filed 2018-11-06
$11.05M
derived: sum of 2 quarters · filed 2018-11-06
$12.98M
10-Q · filed 2018-11-06
2017-06-30$2.31M
10-Q · filed 2018-08-02
$4.24M
10-Q · filed 2018-08-02